JG
PTX

Jefferies Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Jefferies Group’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-342,400
Closed -$1.38M – 2801
2017
Q2 		$1.38M Buy
342,400
+83,200
+32% +$362K 0.01% 1133
2017
Q1 		$959K Buy
+259,200
New +$813K 0.01% 1300
2015
Q1 		– Sell
-2,190
Closed -$206K – 2581
2014
Q4 		$206K Buy
+2,190
New +$209K ﹤0.01% 1741

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jefferies Group's PTX Position: Q4 2016 in Review

Jefferies Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2016, closing a stake of 20,000 shares — an estimated $124K sold.

Jefferies Group first reported a position in PTX in Q1 2015 and held it in 3 quarters. The position peaked at $594K in Q2 2015. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

  • Jefferies Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
  • Jefferies Group sold 20,000 Pernix Therapeutics Holdings, Inc. shares in Q4 2016, an estimated $124K.
  • Jefferies Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2015 and held it in 3 quarters.
  • Jefferies Group's Pernix Therapeutics Holdings, Inc. position peaked at $594K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on Jefferies Group's 13F filing for Q4 2016, filed 14 Feb 2017.